Lewicki John A. 4
4 · Mereo BioPharma Group plc · Filed Jan 26, 2024
Insider Transaction Report
Form 4
Lewicki John A.
Chief Scientific Officer
Transactions
- Award
Share Options (Right to buy)
2024-01-25+137,000→ 137,000 totalExercise: $3.36Exp: 2034-01-25→ American Depository Shares (137,000 underlying)
Footnotes (2)
- [F1]25% of the shares underlying this share option will vest and become exercisable on January 25, 2025, with the remainder vesting in equal monthly installments for the three years thereafter.
- [F2]Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer.